Pharmacology & ToxicologyScience AdvancesPeer-reviewed
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21
Suowen Xu, Zhenghong Liu, Tian Tian…·Jianping Weng
This study shows halofuginone, an FDA-approved drug, reduces obesity in mice by increasing FGF21 and GDF15 levels, improving metabolic health.
13 citations